Brand Insights - Thought Leadership from Marketers I Paid Program | Almac Group

IRT: A Competitive Advantage to Accelerate Clinical Trials

ByBrian Mullin, Brand Insights Contributor, Mgr. of Clinical Project Svcs, Almac Clinical Technologies,Steve McDonald, Brand Insights Contributor, Dir. of Business Dev, Almac Clinical Technologies

June 30th 2020

Brand Insights - Thought Leadership from Marketers | Paid Program

Interactive response technology (IRT) can serve many different functions in clinical research, from patient randomization to making data-driven calculations for patient dosing.

Brand Insights - Thought Leadership from Marketers I Paid Program | Almac Group

IRT: A Competitive Advantage to Accelerate Clinical Trials

Trending on Applied Clinical Trials Online

You've Been Spending Recruitment Money at the Wrong End of the Funnel

ACT Brief: Trial Execution Cost Burden and Protocol Variability, Real-World Oncology Data Curation Complexity, and Real-Time Analytics Datapoint Scale

ACT Brief: NIH Funding Reshaping Development Strategy, Business Decision Setting Execution Course, and Complex Modality Platform Gaps

$500,000 Lost a Day: The Economics of Clinical Trial Execution Is Pharma's Expensive Secret

The Risks That Matter Most for Early-Stage and Rare Disease Programs Right Now